Accumulating evidence has shown amplification of SOX2 gene locus and overexpression of SOX2 that in turn motivates cancer progression, including tumor initiation, EMT, metastasis, recurrence, CSLCs phenotype transformation and drug resistance [60]. The gene discussed is SOX2; the disease is cancer.